Your browser doesn't support javascript.
loading
Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment.
Richardson, Paul G; Hungria, Vânia T M; Yoon, Sung-Soo; Beksac, Meral; Dimopoulos, Meletios Athanasios; Elghandour, Ashraf; Jedrzejczak, Wieslaw W; Guenther, Andreas; Nakorn, Thanyaphong Na; Siritanaratkul, Noppadol; Schlossman, Robert L; Hou, Jian; Moreau, Philippe; Lonial, Sagar; Lee, Jae Hoon; Einsele, Hermann; Sopala, Monika; Bengoudifa, Bourras-Rezki; Corrado, Claudia; Binlich, Florence; San-Miguel, Jesús F.
Afiliação
  • Richardson PG; Dana-Farber Cancer Institute, Boston, MA;
  • Hungria VT; Irmandade da Santa Casa de Misericordia de São Paulo, São Paulo, Brazil;
  • Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
  • Beksac M; Ankara University School of Medicine, Ankara, Turkey;
  • Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece;
  • Elghandour A; Alexandria University, Alexandria, Egypt;
  • Jedrzejczak WW; Medical University of Warsaw, Warsaw, Poland;
  • Guenther A; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University Hospital Schleswig-Holstein and University of Kiel, Kiel, Germany;
  • Nakorn TN; King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand;
  • Siritanaratkul N; Siriraj Hospital, Bangkok, Thailand;
  • Schlossman RL; Dana-Farber Cancer Institute, Boston, MA;
  • Hou J; Chang Zheng Hospital, Shanghai, China;
  • Moreau P; University Hospital of Nantes, Nantes, France;
  • Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA;
  • Lee JH; Department of Internal Medicine, Gachon University Gil Hospital, Incheon, Republic of Korea;
  • Einsele H; Medizinische Klinik und Poliklinik II, University of Würzburg, Würzburg, Germany;
  • Sopala M; Novartis Pharma AG, Basel, Switzerland;
  • Bengoudifa BR; Novartis Pharma AG, Basel, Switzerland;
  • Corrado C; Novartis Pharma AG, Basel, Switzerland;
  • Binlich F; Novartis Pharma SAS, Rueil-Malmaison, France; and.
  • San-Miguel JF; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
Blood ; 127(6): 713-21, 2016 Feb 11.
Article em En | MEDLINE | ID: mdl-26631116
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Ácidos Hidroxâmicos / Indóis / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Ácidos Hidroxâmicos / Indóis / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article